Advanced Search


Study ID Status Title Patient Level Data
200195 Recruiting Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis (or GSK2696273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness
200196 Completed A randomised double blind (sponsor unblinded), single and repeat ascending dose First Time in Human study in healthy subjects, cold urticaria and chronic spontaneous urticaria subjects to investigate safety, tolerability, pharmacodynamics and pharmacokinetics of GSK2646264
200200 Terminated A Phase I Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2879552 Given Orally in Subjects with Relapsed/Refractory Acute Myeloid Leukemia
200207 Terminated A Double Blind, Placebo Controlled, Single and Repeat Dose Escalation Study of GSK2838232 with and without Ritonavir for 8-11 days in Healthy Subjects
200208 Terminated An open label, experimental medicine investigation of the safety and tolerability of 400 mg b.i.d. GSK2586184 in patients with moderate to severely active ulcerative colitis. Study Listed on
200209 Completed A Prospective Study of Sexual Function in Men Taking Dutasteride for the Treatment of Androgenetic Alopecia Study Listed on
200210 Active, Not Recruiting First Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin (mTOR) Inhibitor Therapy among Patients with Advanced/Metastatic Renal Cell Carcinoma in a United States Community Oncology Setting
200211 Active, Not Recruiting Persistence and Compliance among United States Patients Receiving Pazopanib or Sunitinib as First‐Line Therapy for Advanced Renal Cell Carcinoma
200215 Active, Not Recruiting The epidemiology, management patterns, and direct costs of treating malignant melanoma: a retrospective and prospective observational survey using the Canadian Melanoma Research Network (CMRN) Patient Registry
200217 Active, Not Recruiting Treatment retention rate of paroxetine CR in the naturalistic setting (A pilot investigation)
200220 Completed A systematic review and network meta-analysis of IPX066 and other common therapies for management of symptoms in patients with advanced Parkinson’s disease (patients experiencing wearing-off on levodopa therapy)
200226 Completed Adjusting for treatment crossover in a Phase 2 trial of dabrafenib and trametinib combination therapy in patients with metastatic melanoma
200227 Active, Not Recruiting HO-13-9058 - Indirect treatment comparison (ITC) of mepolizumab versus omalizumab in the treatment of adults and adolescents (aged >=12 years) with severe asthma
200229 Completed An Open Label, Randomized, Two Part Study to Evaluate the CYP2C8- and OATP1B1-Mediated Drug-Drug Interaction Potential of GSK1278863 with Pioglitazone and Rosuvastatin as Victims and Trimethoprim as Perpetrator in Healthy Adult Volunteers Study Listed on
200231 Completed A Phase 1, open-label, non-randomized, parallel group, single-dose adaptive study in adults with hepatic impairment and matched, healthy control participants with normal hepatic function
200232 Completed An open-label study in healthy male participants to determine the mass balance, absolute bioavailability and pharmacokinetics of daprodustat, administered as a single intravenous microtracer (concomitant with an oral dose of non-radiolabelled daprodustat) and a single, oral radiolabelled dose
200239 Completed Longitudinal Analysis of Efficacy and Safety of Alitretinoin in Patients with Severe Chronic Hand Eczema Refractory to Corticosteroids
200249 Relinquished A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and MK 3475 in Subjects with Advanced Renal Cell Carcinoma
200252 Completed A single-centre, randomized, open-label, 3-period crossover study using other inhalers as controls, non-pharmacological intervention, to investigate the operability of novel inhaler in subjects who have not previously used any of the inhalers assessed
200254 Completed An Open Label, Single Sequence, Three Period, Drug-Drug Interaction Study To Examine The Pharmacokinetics Of Dutasteride And Tamsulosin And Their Interactions In Chinese Male Healthy Volunteers Study Listed on
200255 Withdrawn Evaluation of antibody persistence for GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (GSK-580299) administered in healthy adults and adolescents, 6.5 years after first vaccination in the primary study
200258 Completed A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression free survival as a surrogate for overall survival
200260 Completed An Open-Label, Randomised, Two Treatment, Four-Way Cross-Over (Replicate Design), Two Sequence, Repeat Dose, Single Centre Study in Healthy Volunteers to Compare the Pharmacokinetics of Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the Low Airflow Resistance ROTAHALER Inhaler Relative to Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the DISKUS Inhaler Study Listed on
200262 Completed A FTIH study with GSK3008348 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis Study Listed on
200274 Active, not recruiting A cohort study to determine the incidence of dengue fever and to build capacity for dengue vaccine trials in dengue-endemic regions of South Asia



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.